JPS5498339A - Carcinostatic agent - Google Patents

Carcinostatic agent

Info

Publication number
JPS5498339A
JPS5498339A JP389878A JP389878A JPS5498339A JP S5498339 A JPS5498339 A JP S5498339A JP 389878 A JP389878 A JP 389878A JP 389878 A JP389878 A JP 389878A JP S5498339 A JPS5498339 A JP S5498339A
Authority
JP
Japan
Prior art keywords
glucopyranosyl
carcinostatic agent
mandelic acid
agent
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP389878A
Other languages
Japanese (ja)
Other versions
JPS5728694B2 (en
Inventor
Setsuo Takeuchi
Mutsuyuki Kochi
Takeo Mizutani
Akira Kawarada
Takeo Nanpata
Mamoru Yokoo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIKEN Institute of Physical and Chemical Research
Original Assignee
RIKEN Institute of Physical and Chemical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIKEN Institute of Physical and Chemical Research filed Critical RIKEN Institute of Physical and Chemical Research
Priority to JP389878A priority Critical patent/JPS5498339A/en
Publication of JPS5498339A publication Critical patent/JPS5498339A/en
Publication of JPS5728694B2 publication Critical patent/JPS5728694B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: To provide a carcinostatic agent containing glucopyranosyl-glucopyranosyl-mandelic acid as an effective component.
CONSTITUTION: Tablet, capsule, injection, etc., containing o-β-D-glucopyranosyl- (1-6)-β-D-glucopyranosyl-mandelic acid and arbitrary carriers or diluents. The agent can be administered orally or parenterally.
EFFECT: Extremely high safety. Remarkable effect to various diseases by oral administration.
COPYRIGHT: (C)1979,JPO&Japio
JP389878A 1978-01-18 1978-01-18 Carcinostatic agent Granted JPS5498339A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP389878A JPS5498339A (en) 1978-01-18 1978-01-18 Carcinostatic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP389878A JPS5498339A (en) 1978-01-18 1978-01-18 Carcinostatic agent

Publications (2)

Publication Number Publication Date
JPS5498339A true JPS5498339A (en) 1979-08-03
JPS5728694B2 JPS5728694B2 (en) 1982-06-18

Family

ID=11569995

Family Applications (1)

Application Number Title Priority Date Filing Date
JP389878A Granted JPS5498339A (en) 1978-01-18 1978-01-18 Carcinostatic agent

Country Status (1)

Country Link
JP (1) JPS5498339A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006058940A1 (en) * 2004-11-29 2006-06-08 Universitat Politècnica De Catalunya Use of amygdalin analogues for the treatment of psoriasis
CN113336808A (en) * 2021-07-22 2021-09-03 成都普思生物科技股份有限公司 Glucoside compound extracted and separated from lily, and method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2356653A1 (en) * 1973-11-13 1975-05-15 Sidus Arzneimittel Gmbh Anti-cancer medicaments contg. amygdalin - causing tumour regression, preventing further tumour growth and having analgesic effect

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2356653A1 (en) * 1973-11-13 1975-05-15 Sidus Arzneimittel Gmbh Anti-cancer medicaments contg. amygdalin - causing tumour regression, preventing further tumour growth and having analgesic effect

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006058940A1 (en) * 2004-11-29 2006-06-08 Universitat Politècnica De Catalunya Use of amygdalin analogues for the treatment of psoriasis
US7956039B2 (en) 2004-11-29 2011-06-07 Universitat Politècnica De Catalunya Use of amygdalin analogues for the treatment of psoriasis
JP4841560B2 (en) * 2004-11-29 2011-12-21 ユニベルシタート ポリテクニカ デ カタルーニャ Use of an amygdalin analog for the treatment of psoriasis
CN113336808A (en) * 2021-07-22 2021-09-03 成都普思生物科技股份有限公司 Glucoside compound extracted and separated from lily, and method and application thereof
CN113336808B (en) * 2021-07-22 2024-02-20 成都普思生物科技股份有限公司 Glycoside compound extracted and separated from lily, and method and application thereof

Also Published As

Publication number Publication date
JPS5728694B2 (en) 1982-06-18

Similar Documents

Publication Publication Date Title
JPS5225013A (en) Insulin pharmaceutical for nasal administration
JPS5234935A (en) Medicinal composition
JPS52128210A (en) Preparation of soft capsule for 1alpha-hydroxyvitamind derivatives
JPS5332124A (en) Carcinostatic agent
JPS52108028A (en) Remedies for dysacousis
JPS57109721A (en) Carcinostatic agent
JPS5350316A (en) Drug composition for oral administration
JPS5498339A (en) Carcinostatic agent
JPS5213681A (en) Connector
JPS55122715A (en) Antidiabetic agent
JPS5793913A (en) Enhancing agent for spermous vital power
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
JPS525769A (en) Preparation of 3-substituted pyrolidine derivatives
JPS5742620A (en) Novel antiulcer agent
JPS5430185A (en) Mandelic acid derivative and carcinostatic agnet containing the same
JPS5346948A (en) Tricyclo(4,3,1,12,5)undecane-1-ol and their preparation
JPS5238506A (en) Detergent composition
JPS5759808A (en) Remedy and preventive for digestive ulcer
JPS51136886A (en) New biologica lly active substance, ml-236c, and its preparation
JPS5295674A (en) Preparation of 4#-substituted-2-methyl-2-piperidinopropiophenone and i ts salts
JPS5422326A (en) 3-trimethylsilymethyl-3-butenoic acid and its preparation
JPS5325534A (en) Mandelic acid glucosides and their anti-cancerous preparations
JPS5569510A (en) Carcinostatic agent
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
JPS5251032A (en) Medicines of disaccharide-glutathione derivatives